Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Will
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(22)
•••
Comment by Mamalikespieon Dec 06, 2018 4:02am
85 Views
Post# 29073935

RE:RE:RE:RE:RE:RE:Will

RE:RE:RE:RE:RE:RE:Will
HighGuy420 wrote:
Look at the net loss history from 2016 and 2017. 
  • Reported a net loss from operations of $1.01 billion, primarily due to $987.1 million of impairments recorded on goodwill, product rights and other intangible assets

sorry, I will clarify my earlier post. ==> Loss created by rectifying the actual value of bad investments made during the buying spree of 2016. I don't see what this has to do with kreppner other than he fixing the shady accounting of the former CEO. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities